Document is current
Any future updates will be listed below
-
Authors
Virgincar, Rohan S.
Nouls, John C.
Wang, Ziyi
Degan, Simone
Qi, Yi
Xiong, Xinyu
Rajagopal, Sudarshan https://orcid.org/0000-0002-3443-5040
Driehuys, Bastiaan
-
Funding
Funding for this research was provided by:
Burroughs Wellcome Career Award for Medical Scientists
U.S. Department of Health & Human Services | National Institutes of Health (R01HL105643)
- License Information
-
More Information
Article History
Received: 15 April 2019
Accepted: 15 April 2020
First Online: 30 April 2020
Competing interests
: B.D. is the founder and chief technology officer for Polarean Imaging, plc, which develops technology related to hyperpolarized <sup>129</sup>Xe MRI. He could benefit from the expanded use of hyperpolarized <sup>129</sup>Xe for preclinical applications. All other authors declare no competing interests.
